查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112256

腹腔鏡婦科手術市場規模、佔有率和趨勢分析報告：按手術類型、應用、地區和細分市場預測（2026-2033 年）

Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report By Procedure, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

腹腔鏡婦科手術市場概述

全球腹腔鏡婦科手術市場預計到 2025 年將達到 205 億美元，從 2026 年的 212 億美元成長到 2033 年的 261 億美元，2026 年至 2033 年的複合年成長率為 3.1%。

北美正在引領市場，到 2025 年，北美將佔據最大的市場佔有率，達到 50.2%。

由於患者對縮短恢復時間和減少疤痕的需求，以及子宮肌瘤和子宮內膜異位症等婦科疾病的日益普遍，再加上微創手術的普及，腹腔鏡婦科手術正在發展壯大。此外，機器人輔助手術等技術的進步也推動了微創手術的發展。

此外，手術機器人正在推動腹腔鏡婦科手術產業的創新，提高了複雜骨盆手術的精準度、可重複性和可及性。諸如「達文西」和「Senhance」平台等先進系統配備了腕式靈活手術器械、高清3D影像和運動縮放功能，使婦科醫生能夠以更高的控制力和更小的創傷完成包括子宮內膜異位症和子宮肌瘤切除術在內的複雜手術。例如，直覺外科公司（Intuitive Surgical）於2025年4月發表的一項新研究強調了機器人輔助手術（RAS）如何克服手術訓練不足和醫院基礎設施落後等障礙，擴大微創醫療的覆蓋範圍，尤其是在醫療服務匱乏的「醫療沙漠」地區。已實施RAS的醫院發現，微創手術率提高，患者群體更加廣泛，患者預後也得到了改善。此外，這些平台透過整合即時分析、人工智慧影像引導和回饋等數位功能，加速了創新，從而改善了手術規劃和術中決策。另外，機器人平台能夠標準化手術技術，不受技術水準差異的影響，這正在改變訓練和認證模式，使複雜的腹腔鏡手術更加普及。

婦科領域對微創腹腔鏡手術技術的需求正因醫師訓練趨勢和技術的融合而進一步成長。越來越多的婦科醫生選擇參加腹腔鏡專科培訓計畫和基於模擬的培訓平台，以提高其在腹腔鏡下全子宮切除術（TLH）、腹腔鏡下保留子宮頸子宮卵巢（LSH）和腹腔鏡下卵巢囊腫切除術等手術中的腹腔鏡技能。市場新進者正透過先進的教育計畫來滿足這一需求。例如，2023年11月，強生旗下醫療技術部門Ethicon在美國婦科和腹腔鏡外科醫師協會（AAGL）世界大會上發布了一款由人工智慧驅動的腹腔鏡手術技能訓練平台。該平台旨在透過為外科醫生提供即時回饋和客觀的績效指標來提高手術培訓品質。人工智慧能夠分析手術技巧並提供個人化指導，從而提陞技能並加速學習。該平台的功能包括對手術表現進行客觀評估、提供個人化回饋以及在模擬環境中進行重複練習的機會，最終目標是改善手術效果。這項創新利用人工智慧最佳化外科醫生的學習過程，代表著外科教育和培訓領域的重大進步。這些措施將進一步提升腹腔鏡手術水平，增強醫療專業人員的能力，並提高微創手術相對於傳統開放性手術的受歡迎程度。

子宮內膜異位症和子宮肌瘤等婦科疾病的日益普遍，顯著地推動了腹腔鏡手術的需求。與開放性手術相比，腹腔鏡手術具有術後併發症更少、恢復更快等優勢，使其成為治療這些疾病的首選標靶微創方法。根據世界衛生組織（WHO）統計，全球約有10%的育齡婦女，約1.9億人，患有子宮內膜異位症。同樣，2023年5月發表在Springer Nature上的一項研究分析了1990年至2019年間全球子宮肌瘤的趨勢，結果顯示，子宮肌瘤的發病率增加了67%，患病率增加了79%，致殘年數增加了77%。利用年齡、時間和世代模型進行的分析表明，社會人口指數（SDI）較低和中等的地區負擔尤其重，發病率在 35 至 44 歲之間達到高峰。婦科手術的增加顯著促進了先進腹腔鏡手術需求的成長。

此外，隨著人們對婦科疾病的認知不斷提高，以及婦科醫療服務可近性的改善，婦科疾病的早期檢測趨勢日益明顯，這使得適合接受腹腔鏡婦科手術的患者群體不斷擴大。這項變化迫使醫療機構加大對腹腔鏡系統和相關訓練的投入。腹腔鏡器械和能量設備的製造商正抓住這一機遇，致力於透過提供特定疾病的工具包（例如用於子宮肌瘤的組織粉碎器和子宮內膜異位症切除工具包）來提高手術效率。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：腹腔鏡婦科手術市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 腹腔鏡婦科手術市場分析工具

第4章 腹腔鏡婦科手術市場：依手術類型分類的估算與趨勢分析

  • 全球腹腔鏡婦科手術市場波動分析
  • 全球腹腔鏡婦科手術市場：依手術類型分類的規模與趨勢分析（2021-2033）
  • 腹腔鏡子宮切除術
  • 腹腔鏡配件手術
  • 腹腔鏡子宮內膜切除術
  • 腹腔鏡診斷程序
  • 腹腔鏡子宮肌瘤切除術
  • 腹腔鏡陰道固定術

第5章：腹腔鏡婦科手術市場：依最終用途分類的估算與趨勢分析

  • 以最終用途分析腹腔鏡婦科手術的全球趨勢。
  • 全球腹腔鏡婦科手術市場：終端使用者規模及趨勢分析（2021-2033年）
  • 醫院
  • 診所
  • 門診手術中心

第6章 腹腔鏡婦科手術市場：區域估算與趨勢分析

  • 2026 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 2026年主要公司市佔率分析
  • Company Position Analysis
  • 公司分類（新興企業、創新者、領導企業）
  • 公司簡介
    • Medtronic
    • Stryker
    • Karl Storz SE & CO. Kg
    • Johnson and Johnson
    • Olympus Corporation
    • CONMED Corporation
    • B. Braun SE
    • CooperCompanies
    • Richard Wolf GmbH
    • Microline Surgical
    • Welfare Medical Ltd.
    • Intuitive Surgical
    • Shenzhen Mindray Bio Medical Electronics Co., Ltd.
Product Code: GVR-4-68039-486-6

Laparoscopic Gynecological Procedures Market Summary

The global laparoscopic gynecological procedures market size was valued at USD 20.5 billion in 2025 and is projected to grow from USD 21.2 billion in 2026 to USD 26.1 billion by 2033, at a CAGR of 3.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 50.2% in 2025.

Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for shorter recovery times and reduced scarring; the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis; and technological advancements, including robotic-assisted surgery.

Moreover, surgical robots are driving innovation in the laparoscopic gynecological procedures industry by enabling enhanced precision, reproducibility, and access in complex pelvic surgeries. Advanced systems such as the da Vinci and Senhance platforms are equipped with wristed instruments, high-definition 3D visualization, and motion scaling, which enable gynecologic surgeons to perform intricate procedures, including endometriosis excision and myomectomy, with enhanced control and minimal invasiveness. For instance, the new study published by Intuitive Surgical in April 2025 highlights that robotic-assisted surgery (RAS) increases access to minimally invasive care, especially in underserved "medical deserts," by overcoming barriers such as limited surgeon training and hospital infrastructure. Hospitals adopting RAS saw higher rates of minimally invasive surgery and expanded access across diverse patient groups, improving patient outcomes. These platforms also accelerate innovation through the integration of digital capabilities, such as real-time analytics, AI-assisted image guidance, and feedback, which collectively improve surgical planning and intraoperative decision-making. Furthermore, the ability of robotic platforms to standardize techniques across varying skill levels is also transforming training and credentialing models, making complex laparoscopic procedures more widely accessible.

The demand for minimally invasive laparoscopic techniques in gynecology is further accelerated by physician training trends and technology integration. Gynecologists are increasingly opting for laparoscopic fellowships and simulation-based training platforms to improve laparoscopic skills, especially for procedures such as total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), and laparoscopic ovarian cystectomy. Market players are responding to this demand with advanced education programs. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, launched an AI-powered laparoscopic skills training platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This platform aims to enhance surgical training by providing surgeons with real-time feedback and objective performance metrics. The AI analyzes surgical techniques, offering personalized guidance to improve skills and accelerate learning. The platform's features include objective assessment of surgical performance, personalized feedback, and opportunities for repeated practice in a simulated environment, ultimately aimed at improving surgical outcomes. This innovation represents a significant advancement in surgical education and training, leveraging AI to optimize the learning process for surgeons. Such initiatives are further enhancing the laparoscopic procedure, offering capabilities of healthcare providers, further increasing the preference towards minimally invasive procedures over traditional open procedures.

The increasing prevalence of gynecological disorders such as endometriosis and uterine fibroids is significantly fueling the demand for laparoscopic interventions. Laparoscopy is increasingly preferred for the diagnosis and treatment of these conditions due to its ability to offer targeted, minimally invasive management with lower postoperative complications and faster recovery compared to open surgery. According to the World Health Organization (WHO), around 10% or approximately 190 million reproductive-age individuals globally are affected by endometriosis. Similarly, a study published in Springer Nature in May 2023 analyzed global trends in uterine fibroids from 1990 to 2019, revealing a 67% increase in incidence, 79% in prevalence, and 77% in years lived with disability. Age-period-cohort modeling indicated rising burdens, especially in low- and middle-Socio-demographic Index regions, with peak incidence at ages 35-44. This rise in gynecological procedures significantly contributesto the rise in demand for advanced laparoscopic procedures.

Moreover, the trend toward early-stage detection of gynecological conditions, driven by increased awareness and access to gynecological care, has expanded the pool of eligible patients for laparoscopic gynecological procedures. This shift is pushing healthcare facilities to invest in laparoscopic systems and training. Manufacturers of laparoscopic instruments and energy devices are capitalizing on this surge by offering disease-specific toolkits, such as fibroid morcellators and endometriosis resection kits, which are increasing procedural efficiency.

Global Laparoscopic Gynecological Procedures Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global laparoscopic gynecological procedures market report based on procedure, end-use, and region:

  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Laparoscopic Hysterectomy
  • Laparoscopic Adnexal
  • Laparoscopic Endometrial Excision
  • Laparoscopic Diagnostic Procedures
  • Laparoscopic Myomectomy
  • Laparoscopic Colpopexy
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Laparoscopic Gynecological Procedures Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Laparoscopic Gynecological Procedures Procedure Market Movement Analysis
  • 4.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
  • 4.4. Laparoscopic Hysterectomy
    • 4.4.1. Laparoscopic Hysterectomy market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Laparoscopic Adnexal
    • 4.5.1. Laparoscopic Adnexal market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Laparoscopic Endometrial Excision
    • 4.6.1. Laparoscopic Endometrial Excision market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Laparoscopic Diagnostic Procedures
    • 4.7.1. Laparoscopic Diagnostic Procedures market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Laparoscopic Myomectomy
    • 4.8.1. Laparoscopic Myomectomy market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.9. Laparoscopic Colpopexy
    • 4.9.1. Laparoscopic Colpopexy market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Laparoscopic Gynecological Procedures End Use Market Movement Analysis
  • 5.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals' market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Ambulatory Surgery Centers
    • 5.6.1. Ambulatory Surgery Centers market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis By Procedure, End Use

  • 6.1. Regional Market Share Analysis, 2026 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2026
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
  • 7.6. Company Profiles
    • 7.6.1. Medtronic
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Stryker
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Karl Storz SE & CO. Kg
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Johnson and Johnson
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Olympus Corporation
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. CONMED Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. CooperCompanies
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Richard Wolf GmbH
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. Microline Surgical
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
    • 7.6.11. Welfare Medical Ltd.
      • 7.6.11.1. Company overview
      • 7.6.11.2. Financial performance
      • 7.6.11.3. Product benchmarking
      • 7.6.11.4. Strategic initiatives
    • 7.6.12. Intuitive Surgical
      • 7.6.12.1. Company overview
      • 7.6.12.2. Financial performance
      • 7.6.12.3. Product benchmarking
      • 7.6.12.4. Strategic initiatives
    • 7.6.13. Shenzhen Mindray Bio Medical Electronics Co., Ltd.
      • 7.6.13.1. Company overview
      • 7.6.13.2. Financial performance
      • 7.6.13.3. Product benchmarking
      • 7.6.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America laparoscopic gynecological procedures market, By country, 2021 - 2033 (USD Million)
  • Table 3 North America laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 4 North America laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 6 U.S. laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 7 Canada laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 8 Canada laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 10 Mexico laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 11 Europe laparoscopic gynecological procedures market, By country, 2021 - 2033 (USD Million)
  • Table 12 Europe laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 13 Europe laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 14 UK laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 15 UK laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 16 Germany laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 17 Germany laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 18 France laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 19 France laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 20 Italy laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 21 Italy laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 23 Denmark laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 25 Sweden laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 26 Norway laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 27 Norway laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific laparoscopic gynecological procedures market, By country, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 31 Japan laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 32 Japan laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 33 China laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 34 China laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 35 India laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 36 India laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 37 Australia laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 38 Australia laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 40 South Korea laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 42 Thailand laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America laparoscopic gynecological procedures market, By Country, 2021 - 2033 (USD Million)
  • Table 44 Latin America laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 45 Latin America laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 47 Brazil laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 48 Argentina laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 49 Argentina laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 50 Middle East & Africa laparoscopic gynecological procedures market, By country, 2021 - 2033 (USD Million)
  • Table 51 Middle East & Africa laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 52 Middle East & Africa laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 53 South Africa laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 54 South Africa laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 55 Saudi Arabia laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 57 UAE laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 58 UAE laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)
  • Table 59 Kuwait laparoscopic gynecological procedures market, By procedure, 2021 - 2033 (USD Million)
  • Table 60 Kuwait laparoscopic gynecological procedures market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Laparoscopic gynecological procedures market: Market outlook
  • Fig. 14 Laparoscopic gynecological procedures market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Laparoscopic gynecological procedures market driver impact
  • Fig. 20 Laparoscopic gynecological procedures market restraint impact
  • Fig. 21 Laparoscopic gynecological procedures market procedure movement analysis
  • Fig. 22 Laparoscopic gynecological procedures market procedure outlook and key takeaways
  • Fig. 23 Laparoscopic hysterectomy market estimates and forecast, 2021 - 2033
  • Fig. 24 Laparoscopic myomectomy market estimates and forecast, 2021 - 2033
  • Fig. 25 Laparoscopic colpopexy market estimates and forecast, 2021 - 2033
  • Fig. 26 Laparoscopic diagnostic procedures market estimates and forecast, 2021 - 2033
  • Fig. 27 Laparoscopic endometrial excision market estimates and forecasts, 2021 - 2033
  • Fig. 28 Laparoscopic adnexal market estimates and forecast, 2021 - 2033
  • Fig. 29 Laparoscopic gynecological procedures market end use movement analysis
  • Fig. 30 Laparoscopic gynecological procedures market end use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecast, 2021 - 2033
  • Fig. 32 Clinics market estimates and forecast, 2021 - 2033
  • Fig. 33 Ambulatory surgery center market estimates and forecast, 2021 - 2033
  • Fig. 34 Global Laparoscopic Gynecological Procedures Market: regional movement analysis
  • Fig. 35 Global Laparoscopic Gynecological Procedures Market: regional outlook and key takeaways
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2021 - 2033
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2021 - 2033
  • Fig. 42 Mexico
  • Fig. 43 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 44 Europe
  • Fig. 45 Europe. market estimates and forecast, 2021 - 2033
  • Fig. 46 UK
  • Fig. 47 UK market estimates and forecast, 2021 - 2033
  • Fig. 48 Germany
  • Fig. 49 Germany market estimates and forecast, 2021 - 2033
  • Fig. 50 France
  • Fig. 51 France market estimates and forecast, 2021 - 2033
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecast, 2021 - 2033
  • Fig. 54 Spain
  • Fig. 55 Spain market estimates and forecast, 2021 - 2033
  • Fig. 56 Denmark
  • Fig. 57 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 58 Sweden
  • Fig. 59 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 60 Norway
  • Fig. 61 Norway market estimates and forecast, 2021 - 2033
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2021 - 2033
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2021 - 2033
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 72 Thailand
  • Fig. 73 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 74 Australia
  • Fig. 75 Australia market estimates and forecast, 2021 - 2033
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 78 Brazil
  • Fig. 79 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa. market estimates and forecasts, 2021 - 2033
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2021 - 2033
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 92 Participant categorization- Laparoscopic gynecological procedures market
  • Fig. 93 Market share of key market players- Laparoscopic gynecological procedures market